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Abstract
Based on the kinetics of interaction between a receptor and G-protein, a myriad of possibilities may result. Two extreme
cases are represented by: 1/Collision coupling, where an agonist binds to the free receptor and then the agonist-receptor
complex ‘‘collides’’ with the free G-protein. 2/Pre-coupling, where stable receptor/G-protein complexes exist in the absence
of agonist. Pre-coupling plays an important role in the kinetics of signal transduction. Odd-numbered muscarinic
acetylcholine receptors preferentially couple to Gq/11, while even-numbered receptors prefer coupling to Gi/o. We analyzed
the coupling status of the various subtypes of muscarinic receptors with preferential and non-preferential G-proteins. The
magnitude of receptor-G-protein coupling was determined by the proportion of receptors existing in the agonist high-
affinity binding conformation. Antibodies directed against the C-terminus of the a-subunits of the individual G-proteins
were used to interfere with receptor-G-protein coupling. Effects of mutations and expression level on receptor-G-protein
coupling were also investigated. Tested agonists displayed biphasic competition curves with the antagonist [
3H]-N-
methylscopolamine. Antibodies directed against the C-terminus of the a-subunits of the preferential G-protein decreased
the proportion of high-affinity sites, and mutations at the receptor-G-protein interface abolished agonist high-affinity
binding. In contrast, mutations that prevent receptor activation had no effect. Expression level of preferential G-proteins
had no effect on pre-coupling to non-preferential G-proteins. Our data show that all subtypes of muscarinic receptors pre-
couple with their preferential classes of G-proteins, but only M1 and M3 receptors also pre-couple with non-preferential Gi/o
G-proteins. Pre-coupling is not dependent on agonist efficacy nor on receptor activation. The ultimate mode of coupling is
therefore dictated by a combination of the receptor subtype and the class of G-protein.
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Introduction
G-protein coupled receptors (GPCR) represent the largest
family of receptors, with more than 900 encoding genes [1]. They
process and transduce a multitude of signals elicited by hormones,
neurotransmitter and odorants and are thus involved in a very
wide array of physiological and pathological processes. This makes
this class of receptors a major pharmacological target for drug
development [2].
Agonist-stimulated GPCRs in turn activate heterotrimeric
GTP-binding proteins (G-proteins) that activate various signaling
pathways. Two distinctive types of interaction between a receptor
and G-protein exist: collision coupling and pre-coupling. In the
former case, an agonist binds to the free receptor, activates it and
then the receptor with bound agonist ‘‘collides’’ with free G-
protein and activates it. In the latter case, stable receptor-G-
protein complexes exist in the absence of agonist, agonist binds to
this complex, induces change in the receptor conformation that
leads to G-protein activation and dissociation of the complex [3].
It should, however, be noted that the distinction between collision
coupling and pre-coupling is rather a matter of kinetics of
receptor-G-protein interaction, activation state and receptor to G-
protein stoichiometry [4]. Additional modes of interaction
intermediate between pure collision coupling and pre-coupling,
like transient receptor to G-protein complexing (‘‘dynamic
scaffolding’’), have been observed [5].
There is accumulating evidence for both collision coupling and
pre-coupling of GPCRs. Interestingly, coimmunoprecipitation
studies showed pre-coupling of a2A-adrenergic receptors [6] with
Gi/o G-proteins and b2-adrenergic receptors with Gs/olf G-proteins
[7]. In contrast, rapid collision coupling of G-proteins with a2A-
adrenergic receptors has been demonstrated in resonance energy
transfer studies [8] and with b2-adrenergic receptors in living cell
imaging studies [9]. Overall, current data on GPCR coupling
suggest that the mode of receptor to G-protein coupling may differ
depending on the receptor type, cell type and membrane
composition [3,10]. Thus, understanding the dynamic behavior of
GPCR systems including receptor-G-protein coupling is important
in discovery and development of more organ-specific drugs.
Muscarinic acetylcholine receptors are GPCRs present at
synapses of the central and peripheral nervous systems but also
exist in non-innervated cells and tissues. There are five subtypes of
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27732muscarinic receptors encoded by distinct genes without splicing
variants [11]. Development of selective ligands for muscarinic
receptors thus represents an enormous challenge due to their
omnipresence, with only a few types of tissues being endowed by a
single or predominant subtype of these receptors. So far very little
is known about the nature of coupling of muscarinic receptors to
G-proteins [12]. We have demonstrated that the M2 receptor can
directly activate all three classes of G-proteins [13], and that it
probably pre-couple to Gi/o but not to Gs/olf G-proteins [14]. To
further clarify the mechanisms of muscarinic receptor subtypes
signaling we analyzed the mode of coupling of M1 through M4
muscarinic receptors with Gi/o,G s/olf and Gq/11 G-proteins in
membranes from Chinese hamster ovary cells expressing individ-
ual receptor subtypes. We show that while M1 and M3 receptors
pre-couple both with their preferential Gq/11 and non-preferential
Gi/o G-proteins, M2 and M4 receptors pre-couple only to
preferential Gi/o G-proteins.
Results
Stimulation of [
35S]GTPcS binding to Gi/o,G s/olf and Gq/11
G-proteins
Membranes from CHO cells containing from 1.4 to 2.5 fmol of
M1 through M4 muscarinic receptors per mg of protein were
exposed to carbachol in concentrations ranging from 0.1 mMt o
1 mM and binding of [
35S]GTPcS to G-protein classes was
determined using a scintillation proximity assay (SPA) (Fig. 1).
Carbacholstimulated [
35S]GTPcS bindingto all three major classes
of G-proteins via all four receptors, with highest potency (EC50
about 1 mM) and efficacy (more than 3-fold increase over basal) for
preferential G-proteins (Gq/11 for M1 and M3 and Gi/o for M2 and
M4 receptors) (Table 1). The potency of carbachol in stimulating
[
35S]GTPcS binding to non-preferential G-proteins was 2- (M3
Gs/olf) to 10-fold (M2 Gs/olf) lower than to preferential G-proteins.
Competition of carbachol with [
3H]NMS binding at M1
through M4 receptors
Binding of the tritiated antagonist N-metylscopolamine
([
3H]NMS) in the presence of agonist carbachol concentrations
ranging from 10 nM to 10 mM (Fig. 2) was best described by
competition for two sites (Eq. 3) at all four receptor subtypes. The
equilibrium inhibition constant (KI) of carbachol was similar
among receptor subtypes, both for high and low affinity sites
(Table 2). At M1 and M3 receptors that preferentially couple to
Gq/11 G-proteins carbachol displayed more low affinity binding
sites than at M2 and M4 receptors that preferentially couple to Gi/o
G-proteins. In some cases preincubation of membranes with
antibodies directed against the C-termini of a-subunits of
individual classes of G-proteins led to an increase in the proportion
of low affinity sites. The proportion of low affinity sites was
increased by anti-Gi/o and anti-Gq/11 antibodies at M1 and M3
receptors but only by anti-Gi/o antibodies at M2 and M4 receptors.
The anti-Gs/olf antibody did not change the proportion of low
affinity sites at any receptor subtype. None of the antibodies
affected KI of either the low or high affinity sites.
Competition of agonists with [
3H]NMS binding at M1 and
M2 receptors
All tested agonists at M1 receptors (carbachol, furmethide,
oxotremorine, and pilocarpine) bound to two binding sites (Fig. 3,
Figure 1. Stimulation of [
35S]GTPcS binding by carbachol. [
35S]GTPcS binding to Gi/o (circles), Gs/olf (squares) and Gq/11 G-proteins (diamonds)
via M1 (upper left), M2 (upper right), M3 (lower left) and M4 (lower right) receptors by increasing concentrations (abscissa, log M) of carbachol is
expressed as fold over basal (ordinate). Data are means 6 S.E.M of values from 3 experiments performed in quadruplicates. Curves were fitted using
equation 2 and results of fits are shown in Table 1.
doi:10.1371/journal.pone.0027732.g001
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recognized the same proportion of low-affinity sites (Table 3).
Anti-Gi/o and anti-Gq/11 antibodies increased the proportion of
low affinity sites to a comparable extent for all tested agonists
(Fig. 3, open circles and open diamonds). The anti-Gs/olf antibody
did not change the proportion of the low-affinity binding sites for
any of the agonists tested (Fig. 3, open squares). None of the
antibodies affected KI values.
Similarly, all tested agonists bound to two binding sites at M2
receptors (Fig. 4, full circles). As in the case of the M1 receptor they
bound with different affinities but they recognized the same
proportion of low-affinity sites (Table 4). Similar to carbachol, the
proportion of low-affinity sites was lower at M2 than at M1
receptors for all tested agonists (Table 4 vs. Table 3) and only the
anti-Gi/o antibody increased the proportion of low affinity sites
(Fig. 4, open circles). The anti-Gs/olf and anti Gq/11 antibodies did
not change either the proportion of low-affinity binding sites or
KIs for any of the agonists tested (Fig. 4, open squares and open
diamonds).
Effects of mutations of M1 receptors that affect receptor
activation
To further investigate the role of receptor activation in
receptor-G-protein pre-coupling we prepared cell lines expressing
mutant M1 receptor with mutations known to interfere with
receptor signaling. Mutation of aspartate 71 in the middle of the
second transmembrane domain to asparagine (D71N) has been
shown to abolish receptor activation [15]. Mutation of aspartate
122 in the conserved E/DRY-motif at the intracellular edge of
the third transmembrane domain to asparagine (D122N) has
been shown to reduce the potency of muscarinic agonists [16].
Opsin arginine in the conserved E/DRY-motif at the intracel-
lular edge of the third transmembrane domain of has been shown
to directly interact with the C-terminal cysteine of the a-subunit
of G-protein [16]. At M1 muscarinic receptors mutation of
corresponding arginine 123 asparagine (R123N) blocks activation
of G-proteins [17]. The appropriate control CHO cell line
expressing the wild-type receptor was also generated using the
same expression vector. Expression levels of receptor mutants
Figure 2. Effects of anti-G-protein antibodies on competition between carbachol and [
3H]NMS binding at M1 to M4 receptors.
Binding of 1 nM [
3H]NMS to membranes from CHO cells expressing M1 (upper left), M2 (upper right), M3 (lower left) and M4 (lower right) receptors in
the presence of increasing concentrations (abscissa, log M) of carbachol is expressed as per cent of control binding in the absence of carbachol. Filled
circles, control binding in the absence of antibodies. Open symbols, binding in the presence of anti-Gi/o (circles), anti-Gs/olf (squares), and anti-Gq/11
(diamonds) antibodies. Data are means 6 S.E.M of values from 3 experiments performed in quadruplicates. Curves were fitted using equation 3 and
results of fits are shown in the Table 2.
doi:10.1371/journal.pone.0027732.g002
Table 1. Stimulation of [
35S]GTPcS binding by carbachol to
Gi/o,G s/olf and Gq/11 subtypes of G-proteins via M1 through M4
receptors.
Gi/o Gs/olf Gq/11
pEC50 EMAX pEC50 EMAX pEC50 EMAX
M1 5.3160.05 2.0160.05 5.4460.05 1.9260.05 5.9660.05 3.9060.08
M2 6.0160.06 3.4460.07 5.0160.06 1.9360.05 5.2460.02 1.63 60.02
M3 5.3260.05 2.1660.06 5.5460.05 2.1660.05 5.8360.04 3.3160.06
M4 5.8960.05 3.1560.08 5.1860.06 2.1860.06 5.4960.05 1.5960.04
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. EMAX
is expressed as fold increase of basal binding.
doi:10.1371/journal.pone.0027732.t001
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level of the wild-type receptor (0.63 to 0.71 pmol per mg of
protein).
Association of 0.5 nM [
35S]GTPcS with membranes from the
newly prepared CHO cell line expressing M1 receptors occurred
with observed association rate kobs= 0.036 min
-1 (Fig. 5 upper
left, full circles, and Table 5). One hundred mM carbachol (Fig. 5,
open circles) accelerated association of [
35S]GTPcS two-times and
increased equilibrium binding (Beq) by one third. Mutations D71N
(Fig. 5 upper right) and R123N (Fig. 5 lower right) did not change
basal (in the absence of carbachol) association of [
35S]GTPcS but
they both abolished acceleration induced by carbachol. Mutation
D122N accelerated basal association of [
35S]GTPcS by 50%. One
hundred mM carbachol further accelerated association of
[
35S]GTPcS. The rate of association as well as Beq in the presence
of carbachol at R123N receptors was the same as at control (M1
wt) (Fig. 5 and Table 5).
On the newly prepared cell line expressing M1 wt receptors
carbachol displayed binding to two binding sites in competition
with [
3H]NMS with the same proportion of low affinity sites and
similar affinities (Fig. 6, full circles) as in Fig. 2. While mutation
D71N did not change the binding parameters of carbachol,
mutation D122N brought about an increase in low affinity sites
and mutation R123N completely abolished high-affinity binding
(Fig. 6 and Table 6).
Figure 3. Effects of anti-G-protein antibodies on competition between different agonists and [
3H]NMS binding at M1 receptors.
Binding of 1 nM [
3H]NMS to membranes from CHO cells expressing M1 receptors in the presence of increasing concentrations (abscissa, log M) of the
agonists carbachol (upper left), furmethide (upper right), oxotremorine (lower left) and pilocarpine (lower right) is expressed as per cent of control
binding in the absence of agonist. Filled circles, control binding in the absence of antibodies. Open symbols, binding in the presence of anti-Gi/o
(circles), anti-Gs/olf (squares) and anti-Gq/11 (diamonds) antibodies. Data are means 6 S.E.M of values from 3 experiments performed in quadruplicates.
Curves were fitted using equation 3 and results of fits are shown in Table 3.
doi:10.1371/journal.pone.0027732.g003
Table 2. Effects of IgG antibodies directed against the a-
subunits of individual subtypes of G-proteins on binding
parameters of carbachol in membranes of CHO cells
expressing individual subtypes of muscarinic receptors.
control anti-Gi/o anti-Gs/olf anti-Gq/11
M1 pKi high 7.0160.08 6.9360.09 7.0960.08 7.1460.08
pKil o w 5.2160.07 5.2560.06 5.2760.07 5.3060.07
f low 69678 4 68* 74679 2 68*
M2 pKi high 6.8160.08 6.7060.07 6.9360.08 6.8860.07
pKil o w 5.0160.07 5.1360.07 5.0660.07 5.0160.08
f low 56688 9 68* 61695 4 69
M3 pKi high 7.0360.08 7.1560.09 7.2360.08 7.1460.09
pKil o w 5.1560.09 5.2060.09 5.2360.08 5.2760.09
f low 72678 9 69* 76679 2 68*
M4 pKi high 6.9160.09 7.0360.08 7.0960.09 6.9460.08
pKil o w 5.0160.09 4.9560.08 5.0860.09 5.00 60.08
f low 62678 2 68* 66675 8 67
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. flow,
fraction of low-affinity sites in percent;
*, significantly different from control by t-test (P,0.05).
doi:10.1371/journal.pone.0027732.t002
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M2-CHO cells
Total binding capacity of (saturating) 500 nM [
35S]GTPcSi n
control M2-CHO membranes (in the absence of GDP) showed
prevalence of Gi/o G-proteins over Gs/olf and Gq/11 (37.563.9,
22.062.3 and 25.462.8 pmol/mg prot., respectively; mean 6
S.E.M., n=3). Treatment of M2-CHO cells with siRNA directed
to Gi/o G-proteins resulted in more than a 70% decrease in the
[
35S]GTPcS binding capacity of Gi/o (10.161.8 pmol/mg prot.;
mean 6 S.E.M., n=3) without a change in the binding capacity
of Gs/olf and Gq/11 G-proteins (24.162.2, 23.862.5 pmol/mg
prot., respectively; mean 6 S.E.M., n=3). This treatment
resulted in a 10-fold decrease in the potency of carbachol in
stimulation of [
35S]GTPcS binding to Gi/o G-proteins (Fig. 7 vs.
Fig. 1 upper right, open circles; Table 7 vs. Table 1) and
decreased its efficacy more than 5-times. The efficacy of
carbachol in stimulation of [
35S]GTPcS binding to Gs/olf or
Gq/11 G-proteins was unchanged while its potency increased
about 3-times in both cases.
Based on competition binding of agonists and [
3H]NMS (Fig. 8;
Table 8), attenuation of Gi/o expression led to an increase in the
proportion of low-affinity sites for all tested agonists (see controls in
Table 4 and Table 8) without change in KI values. The anti-Gi/o
antibody further increased the proportion of low-affinity sites in
Gi/o G-proteins-depleted membranes only for the full agonists
carbachol and furmethide. In contrast to control M2-CHO cells,
the proportion of low-affinity sites of the partial agonists
oxotremorine and pilocarpine in Gi/o G-proteins-depleted mem-
Table 3. Effects of IgG antibodies directed against a-subunits
of individual subtypes of G-proteins on binding parameters of
different muscarinic agonists in membranes of M1 CHO cells.
Control anti-Gi/o anti-Gs/olf anti-Gq/1
carbachol pKi high 7.0160.08 6.9360.09 7.0960.08 7.1460.08
pKil o w 5.2160.07 5.2560.06 5.2760.07 5.3060.07
f low 69678 6 68* 74679 2 68*
furmethide pKi high 6.7060.07 6.5960.08 6.6660.07 6.6360.08
pKil o w 4.8260.07 4.7860.07 4.8160.07 4.8760.07
f low 62678 4 68* 62669 2 68*
oxotremorine pKi high 8.1260.08 8.0460.8 7.9660.06 8.1460.08
pKil o w 6.5360.06 6.4760.07 6.4660.06 6.4960.06
f low 69669 0 68* 69669 5 65*
pilocarpine pKi high 7.7260.07 7.6460.07 7.6160.07 7.6660.07
pKil o w 5.8460.06 5.8160.06 5.8060.06 5.7160.06
f low 75679 2 68* 73679 0 68*
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. flow,
fraction of low-affinity sites in percent;
*, significantly different from control by t-test (P,0.05).
doi:10.1371/journal.pone.0027732.t003
Figure 4. Effects of anti-G-protein antibodies on competition between different agonists and [
3H]NMS binding at M2 receptors.
Binding of 1 nM [
3H]NMS to membranes from CHO cells expressing M2 receptors in the presence of increasing concentrations (abscissa, log M) of the
agonists carbachol (upper left), furmethide (upper right), oxotremorine (lower left) and pilocarpine (lower right) is expressed as per cent of control
binding in the absence of agonist. Filled circles, control binding in the absence of antibodies. Open symbols, binding in the presence of anti-Gi/o
(circles), anti-Gs/olf (squares) and anti-Gq/11 (diamonds) antibodies. Data are means 6 S.E.M of values from 3 experiments performed in quadruplicates.
Curves were fitted using equation 3 and results of fits are shown in Table 4.
doi:10.1371/journal.pone.0027732.g004
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untreated M2-CHO cells, the anti-Gs/olf and anti-Gq/11 antibodies
had no effect on either the proportion of low affinity sites or KI
values in membranes with attenuated expression of Gi/o G-
proteins.
Discussion
Binding of an agonist to a G-protein-coupled receptor (GPCR)
results in transforming the receptor to an active state that
facilitates guanosine diphosphate (GDP) dissociation from the a-
subunit of interacting heterotrimeric G-proteins and its exchange
for guanosine trisphosphate (GTP) [18]. In principle there are
many possible ways for receptor-G-protein interactions to take
effect, with two extreme possibilities. In one scenario receptors and
G-proteins diffuse freely within the plasma membrane, agonist
binds to the free receptor that then randomly ‘‘collides’’ with G-
proteins and activates them. Alternatively, receptors and G-
proteins form stable complexes regardless of the receptor
activation state and agonist binding, the agonist binds to this
complex and induces conformational changes in the receptor
protein that leads to G-protein activation and dissipation of the
receptor-G-protein complex. We will refer to the former situation
as ‘‘collision coupling’’ and the latter one as ‘‘pre-coupling’’ [3]. It
should, however, be noted that even if receptors are partially pre-
coupled to G-proteins, an agonist can also bind to free receptors
and then ‘‘collide’’ with G-protein. Also the distinction between
collision coupling and pre-coupling is rather a matter of kinetics of
Table 4. Effects of IgG antibodies directed against a-subunits
of individual subtypes of G-proteins on binding parameters of
different muscarinic agonists in membranes of M2 CHO cells.
Control anti-Gi/o anti-Gs/olf anti-Gq/1
carbachol pKi high 6.8160.08 6.7060.07 6.9360.08 6.8860.07
pKil o w 5.0160.07 5.1360.07 5.0660.07 5.0160.08
f low 56688 9 68* 61695 4 69
furmethide pKi high 6.9960.08 6.9860.07 7.1960.07 7.0860.08
pKil o w 4.7060.08 4.7960.07 4.8460.08 4.7360.07
f low 48688 0 67* 49685 3 69
oxotremorine pKi high 7.7460.09 7.7660.08 7.8360.08 7.9360.08
pKil o w 6.1760.08 5.7860.08 6.2260.09 6.2760.08
f low 60688 4 67* 65686 1 67
pilocarpine pKi high 7.1060.09 7.0560.11 7.2260.09 7.0060.10
pKil o w 5.5860.09 5.6760.09 5.6260.09 5.6060.09
f low 53610 76611
* 53610 57611
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. flow,
fraction of low-affinity sites in percent;
*, significantly different from control by t-test (P,0.05).
doi:10.1371/journal.pone.0027732.t004
Figure 5. Effects of point mutations of the M1 receptor on carbachol-induced stimulation of of [
35S]GTPcS. Binding of 0.5 nM
[
35S]GTPcS to all G-proteins in the presence of 50 mM GDP was measured in membranes from newly prepared CHO cell lines expressing either wild-
type (M1 wt) or mutant (D71N, D122N, R123N) M1 receptors in the absence (full circles) or in the presence (open circles) of 100 mM carbachol. Data are
means 6 S.E.M of values from 3 experiments performed in quadruplicates. Curves were fitted using equation 4 and results of fits are shown in Table 5.
doi:10.1371/journal.pone.0027732.g005
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protein stoichiometry [4]. Thus a myriad of possible ways for
interaction among receptor, G-protein and agonist exist, e.g.,
transient receptor to G-protein complexing (‘‘dynamic scaffold-
ing’’) [5]. Receptor G-protein pre-coupling plays an important role
in signaling. It may accelerate kinetics of signal transduction. If
receptor G-protein complexes pre-exist, instantaneous activation
of G-protein takes place upon agonist binding to the receptor [4].
As shown repeatedly [10,13,19,20] and also in Fig. 1,
muscarinic acetylcholine receptors couple with all 3 major classes
of G-proteins (Gi/o,G s/olf and Gq/11). Our recent data show that
at M2 receptors the agonist carbachol slows down the association
of GDP with Gi/o but not Gs/olf G-proteins [14]. This finding may
evidence the pre-existence of a receptor/G-protein complex prior
to carbachol binding. Data thus suggest that muscarinic M2
receptors pre-couple to Gi/o but not to Gs/olf G-proteins.
Alternatively, M2 receptors may precouple with Gs/olf but
carbachol has no effect on GDP association. To exclude this
possibility we analyzed in detail pre-coupling of all 3 major classes
of G-proteins with M2 receptors and compared it with pre-
coupling at other Gi/o preferring (M4) and Gq/11 preferring (M1
and M3) muscarinic receptors.
At all receptor subtypes carbachol displays a ‘‘two site’’ binding
curve with high affinity binding in the nanomolar range and low
affinity binding in the micromolar range (Fig. 2, Table 2).
According to the ternary complex model of GPCRs [21] agonists
bind with high affinity to the receptor-G-protein complex and with
low-affinity to receptors uncoupled from G-proteins. The interface
of interaction between the receptor and G-protein consists of the
intracellular edge of the third, fifth and sixth transmembrane
domains and adjacent parts of the third and fourth intracellular
loops of the receptor and the C-terminus of the G-protein a-
subunit [16,22]. Antibodies directed against the C-terminus of G-
protein should prevent receptor-G-protein interaction (or break
existing receptor G-protein complex) and lower the affinity of the
receptor for agonists. Indeed, IgG antibodies directed against the
C-terminus of the Gi/o class of G-proteins increased the fraction of
low-affinity sites at all receptor subtypes including the Gi/o non-
preferring M1 and M3 receptors. Similarly, IgG antibodies
directed against the C-terminus of Gq/11 class of G-proteins
increased the fraction of low-affinity sites only at their preferring
M1 and M3 receptors, but IgG antibodies directed against the C-
terminus of Gs/olf class of G-proteins had no effect. Antibodies
only changed the proportion of low-affinity sites without an effect
on receptor affinity. Our data also show that all receptors pre-
couple with their preferential G-proteins (M1 and M3 with Gq/11
and M2 and M4 with Gi/o) and that M1 and M3 receptors also pre-
couple with non-preferential Gi/o G-proteins. In contrast, pre-
coupling of Gs/olf G-proteins was not detected at any subtype of
muscarinic receptors. In other words, the interaction between
receptor and Gs/olf is so short-lived that cannot be detected by
antibodies. This is in agreement with our kinetic measurements at
Gs/olf and M2 receptors [14].
Table 5. Rates of basal and carbachol-stimulated association of [
35S]GTPcS in CHO membranes expressing wild type and mutant
M1 receptors.
M1 wt D71N D122N R123N
control kobs [min
-1] 0.03660.007 0.03460.007 0.05460.005# 0.03860.007
Beq
[fmol/:g prot.]
101661 0 7 612 103681 0 5 66
+100 mM carbachol kobs [min
-1] 0.07560.006* 0.03360.006# 0.07760.005* 0.03660.007#
Beq
[fmol/mg prot.]
13368* 10569# 12666* 10065#
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates.
*, Significantly different from control;
#, significantly different from wild type (M1 wt), t-test (P,0.05).
doi:10.1371/journal.pone.0027732.t005
Figure 6. Effects of point mutations of the M1 receptor on
competition between carbachol and [
3H]NMS binding. Binding
of 1 nM [
3H]NMS to membranes from newly prepared CHO cell lines
expressing wild type and mutant M1 receptors in the presence of
increasing concentrations carbachol is expressed as per cent of control
binding in the absence of agonist. Filled circles, binding to wild-type M1
receptors. Open symbols, binding to D71N (circles), D122N (squares)
and R123N (triangles) mutatant M1 receptors. Data are means 6 S.E.M
of values from 3 experiments performed in quadruplicates. Curves were
fitted using equation 3 and results of fits are shown in Table 6.
doi:10.1371/journal.pone.0027732.g006
Table 6. Effects of single amino acid mutations of M1
receptor on the binding parameters of carbachol.
M1 control D71N D122N R123N
pKi high 7.1360.08 7.0160.08 7.0760.09
pKil o w 4.9160.06 4.8560.05 4.9260.05 4.8060.07
f low 72667 4 678 6 67* 9961*
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. flow,
fraction of low-affinity sites in percent;
*, significantly different from control by t-test (P,0.05).
doi:10.1371/journal.pone.0027732.t006
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(carbachol, furmethide, oxotremorine and pilocarpine) that also
differ in potency and efficacy in activating muscarinic receptors
[14] and binding kinetics [23]. Importantly, all tested agonists
recognize the same proportion of low-affinity binding sites (Figs 3
and 4; Tables 3 and 4). It is very unlikely that these agonists induce
the same proportion of transient high-affinity states (in collision
coupling, dynamic scaffolding or a similar scenario). Rather
receptor G-protein complexes preexist prior to agonists binding
and their proportion is given by stoichiometry of receptors and G-
proteins. Moreover, the antibodies have the same effect on binding
of all agonists, further excluding the role of agonists in the
formation of receptor-G-protein complexes.
To further investigate the role of receptor activation in receptor-
G-protein pre-coupling we prepared cell lines expressing mutant
M1 receptor with mutations known to interfere with receptor
signaling. Mutation of aspartate 71 in the middle of the second
transmembrane domain to asparagine (D71N) has been shown to
prevent activation of the M1 receptor [15]. This residue is neither
part of the agonist binding site nor the receptor-G-protein
interface. It is supposed that the D71N mutation disrupts
intramolecular hydrogen bond network and prevents the receptor
from gaining an active conformation. Its effect on suppressing
receptor activation is confirmed in Fig. 5 (upper right). Although
D71N receptors cannot be activated by carbachol they still display
both high- and low-affinity sites for carbachol with the same
proportion as control wild-type M1 receptors (Fig. 6, full and open
circles). Thus, an active conformation of the receptor is not a
prerequisite for receptor-G protein pre-coupling. These data are in
perfect fit with a report by Quin et al. [24] published during
completion of this manuscript that M3 receptors form inactive
complexes with Gq G-proteins.
In contrast, mutations that interfere with receptor signaling by
being directed against the receptor G-protein interface do affect
pre-coupling. Mutation of aspartate 122 in the conserved E/DRY-
motif at the intracellular edge of the third transmembrane domain
to asparagine (D122N) has been shown to reduce the potency of
muscarinic agonists [13]. Measurements of the association rate of
GTPcS shows that at D122N receptors GTPcS binding under
basal conditions (in the absence of agonist) is accelerated and that
carbachol has smaller effect on GTPcS association rate than at
wild-type M1 receptors (Fig. 5, lower left). Meanwhile, the
proportion of low-affinity sites for carbachol is increased in
D122N receptors in comparison with control (Fig. 6). Most likely,
increased basal activity of D122N results in more activated G-
proteins and thus more uncoupled receptors in membrane
preparations. Crystal structure of complex of opsin and C-
terminus of G-protein a-subunit revealed that arginine in the
conserved E/DRY-motif at the intracellular edge of the third
transmembrane domain interacts directly with the a-subunit C-
terminal cysteine [16]. At M1 muscarinic receptors mutation of
arginine 123 to asparagine (R123N) blocks activation of G-
proteins (Fig. 5, lower right). In accordance with the ternary
complex model of GPCRs [21], R123N receptors (uncoupled from
G-proteins) display only low-affinity for carbachol (Fig. 6,
triangles).
It is worth noting that carbachol can activate all three classes of
G-proteins at both M1 and M2 receptors (Fig. 1) and M1 receptors
pre-couple both to preferential Gq/11 and non-preferential Gi/o G-
proteins. In contrast, M2 receptors pre-couple only to preferential
Gi/o G-proteins. Gi/o are the major class of G-proteins in
membranes from CHO cells, representing almost half of all G-
proteins. To exclude the possibility that M2 receptors do not pre-
couple with Gq/11 G-proteins due to competition with preferential
Gi/o G-proteins, we attenuated the expression of Gi/o a-subunits
by siRNA to one quarter, making Gi/o G-proteins the least
abundant class in CHO membranes. Such reduction in expression
of Gi/o G-proteins diminishes the efficacy of carbachol in
activating these preferential G-proteins to a level lower than at
any of non-preferential G-proteins (Fig. 7). It also reduced its
potency (Table 7 vs. Table 1). On the other hand, the potency of
carbachol to stimulate GTPcS binding increases at non-preferen-
tial Gs/olf and Gq/11 G-proteins, demonstrating competition
among G-proteins for M2 receptors [25]. In concert, the
proportion of low-affinity sites increases and the effect of the
anti-Gi/o antibody is reduced (Fig. 8, cf. Table 4 and Table 8).
Again, these findings indicate the presence of a lower proportion of
high-affinity receptor/G-protein complexes. However, the anti-
Gq/11 antibody has no effect on the proportion of low-affinity sites
even after such reduction in the expression of Gi/o G-proteins.
This suggests that the lack of pre-coupling of Gq/11 G-proteins
with M2 receptors is not due to competition with Gi/o G-proteins.
In summary, we show that muscarinic receptors pre-couple with
their preferential class of G-proteins in the absence of an agonist.
In contrast to the M1 and M3 receptors that pre-couple both with
preferential Gq/11 and non-preferential Gi/o G-proteins, the M2
and M4 receptors pre-couple only with their preferential Gi/o G-
Figure 7. Stimulation of [
35S]GTPcS binding by carbachol at the
M2 receptor after suppression of expression of Gi/o G-proteins.
M2 receptor-mediated stimulation of [
35S]GTPcS binding to Gi/o (circles),
Gs/olf (squares) and Gq/11 G-proteins (diamonds) after suppression of
expression of Gi/o G-proteins by siRNA was stimulated by increasing
concentrations of carbachol (abscissa, log M). Response is expressed as
fold over basal (ordinate). Data are means 6 S.E.M of values from 3
experiments performed in quadruplicates. Curves were fitted using
equation 2 and results of fits are shown in Table 5.
doi:10.1371/journal.pone.0027732.g007
Table 7. Stimulation of [
35S]GTPcS binding by carbachol via
M2 receptors to Gi/o,G s/olf and Gq/11 subtypes of G-proteins in
membranes with reduced expression of the Gi/o subclass of G-
proteins.
pEC50 EMAX
Gi/o 5.0160.06 1.4360.08
Gs/olf 5.5460.05 1.8260.06
Gq/11 5.6560.05 1.6360.04
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. EMAX
is expressed as fold increase of basal binding.
doi:10.1371/journal.pone.0027732.t007
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Gq/11 G-proteins is not due to competition with preferential Gi/o
G-proteins. None of the four subtypes of muscarinic receptors pre-
couples to Gs/olf G-proteins. Thus, the mode of coupling of a given
subtype of muscarinic receptors is governed by a combination of
the receptor subtype and the class of G-protein. Advanced
instrumental methods like fluorescence resonance energy transfer
(FRET) between receptor and G-protein [7] and plasmon surface
resonance [5] were developed to monitor kinetics of receptor G-
protein interactions. Although these methods give better picture of
receptor G-protein interaction, our simple method, that can only
detect pre-coupling, does not require recombinant systems like
FRET-based methods nor reconstituted systems like plasmon
surface resonance methods and can be easily applied ex vivo, e.g. to
tissues of experimental animals.
Materials and Methods
Materials
The radioligands [
3H]-N-methylscopolamine chloride ([
3H]NMS),
guanosine-59-c[
35S]thiotriphosphate ([
35S]GTPcS), and anti-rabbit
IgG-coated scintillation proximity beads were from Amersham (UK).
Rabbit polyclonal antibodies against C-terminus of G-protein (Gi/o,
C-10, and Gs/olf, C-18) were from Santa Cruz Biotechnology (Santa
Cruz, CA). Carbamoylcholine chloride (carbachol), dithiotreitol,
ethylendiaminotetraacetic acid (EDTA), guanosine-59-biphosphate
Figure 8. Effects of anti-G-protein antibodies on competition between agonists and [
3H]NMS binding at M2 receptors after
suppression of Gi/o G-proteins expression. Binding of 1 nM [
3H]NMS to membranes from CHO cells expressing M2 receptors after suppression of
expression of Gi/o G-proteins by siRNA was determined in the presence of increasing concentrations (abscissa, log M) of the agonists carbachol (upper
left), furmethide (upper right), oxotremorine (lower left), and pilocarpine (lower right). Binding is expressed as per cent of control binding in the
absence of agonist. Filled circles, control binding in the absence of antibodies. Open symbols, binding in the presence of anti-Gi/o (circles), anti-Gs/olf
(squares) and anti-Gq/11 (diamonds) antibodies. Data are means 6 S.E.M of values from 3 experiments performed in quadruplicates. Curves were fitted
using equation 3 and results of fits are shown in Table 6.
doi:10.1371/journal.pone.0027732.g008
Table 8. Effects of IgG antibodies directed against a-subunits
of individual subtypes of G-proteins on binding parameters of
muscarinic agonists in membranes of M2 CHO cells with
reduced expression of Gi/o G-proteins by siRNA.
control anti-Gi/o anti-Gs/olf anti-Gq/11
carbachol pKi high 6.8560.08 6.8960.07 6.9460.08 6.7760.07
pKil o w 5.0360.07 4.8860.07 4.9860.07 4.9560.08
f low 73689 0 68* 75697 2 69
furmethide pKi high 7.0760.08 6.7260.07 7.9160.07 6.9760.08
pKil o w 4.7260.08 4.6860.07 4.6960.08 4.7160.07
f low 72678 6 67* 69687 2 69
oxotremorine pKi high 7.5560.09 7.5460.08 7.7660.08 7.6360.08
pKil o w 6.0960.08 6.1560.08 6.1760.09 6.2560.08
f low 78688 9 678 4 687 9 67
pilocarpine pKi high 7.0060.09 6.9160.11 7.0660.09 7.3160.10
pKil o w 5.5560.09 5.5860.09 5.5460.09 5.6260.09
f low 72611 87612 76610 73611
Data are means 6 S.E.M. From 3 experiments performed in quadruplicates. flow,
fraction of low-affinity sites in percent;
*, significantly different from control by t-test (P,0.05).
doi:10.1371/journal.pone.0027732.t008
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salt (GTPcS), N-methylscopolamine bromide (NMS), and pilocar-
pine hydrochloride were from Sigma (St. Louis, MO). Oxotremorine
sesquifumarate was from RBI (Natick, MA) and Nonidet P-40 was
from USB Corporation (Cleveland, OH). Furfuryltrimethylammo-
nium bromide (furmethide) was kindly donated by Dr. Shelkovnikov
(University of St. Petersburg). Small interfering RNA (siRNA) was
designed and synthesized by Ambion/Applied Biosystems, Czech
Republic.
Cell culture and membrane preparation
Chinese hamster ovary cells stably transfected with the human
M1 to M4 muscarinic receptor genes (CHO cells) were kindly
donated by Prof. T.I.Bonner (National Institutes of Health,
Bethesda, MD). Cell cultures and crude membranes were prepared
as described previously [18]. Briefly, cells were grown to confluency
in 75 cm
2 flasks in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum. Two million of cells were
subcultured to 100 mm Petri dishes. Medium was supplemented
with 5 mM butyrate for the last 24 hours of cultivation to increase
receptor expression. Cells were detached by mild trypsinization on
day5 aftersubculture.Detached cellswere washedtwice in50 mlof
phosphate-buffered saline and 3 min centrifugation at 250 x g.
Washed cells were suspended in 20 ml of ice-cold incubation
medium (100 mM NaCl, 20 mM Na-HEPES, 10 mM MgCl2;
pH=7.4) supplemented with 10 mM EDTA and homogenized on
ice by two 30 sec strokes using Polytron homogenizer (Ultra-
Turrax; Janke & Kunkel GmbH & Co. KG, IKA-Labortechnik,
Staufen, Germany) with a 30-sec pause between strokes. Cell
homogenates were centrifuged for 30 min at 30,000 x g. Superna-
tants were discarded, pellets resuspended in fresh incubation
medium and centrifuged again. Resulting membrane pellets were
kept at 220uC until assayed within 10 weeks at a maximum.
Attenuation of expression of Gi/o G-proteins
Expression of Gi/o G-proteins a-subunits was attenuated by si-
RNAs of following sequences (59-.39 sense): Go, GGC UCC AAC
ACC UAU GAA Gtt; Gi1, CCU CAA CAA AAG AAA GGA Ctt;
Gi2, CCU CCA UCA UCC UCU UCC Utt; Gi3, GGG AGU
GAC AGC AAU UAU Ctt. Cells were treated with complexes of
all 4 siRNAs and lipofectamine 48 hours prior to experiment.
Final concentrations were 50 nM for each siRNA and 0.5 vol. %
for lipofectamine.
Preparation of new stable cell lines
New stableCHO cell lines expressing wild-type M1and mutant M1
receptors have been prepared. Coding sequence of wild-type human
M1 muscarinic receptor (in expression vector pcDNA ver. 3.2, cDNA
resource center, University of Missouri-Rolla, MO, USA) was
mutated by PCR and mismatch primers using Qiagene QuickChange
kit. Mutations were verified by sequencing of complete receptor
coding sequence. Then CHO-K1 cells were transfected with either
original M1-pcDNA or mutated plasmid using Lipofectamine 2000
(Lipofectamie 10 ml/ml, DNA 0.5 mg/ml). After 48 hours geneticine
was added to cultivation medium to final concentration of 800 mg/ml.
After selection, the concentration of geneticine was lowered to 50 mg/
ml and maintained during cultivation.
Equilibrium radioligand binding experiments
All radioligand binding experiments were optimized and carried
out as described earlier [20]. Briefly, membranes were incubated
in 96-well plates at 30
oC in the incubation medium described
above that was supplemented with freshly prepared dithiothreitol
at a final concentration of 1 mM. Incubation volume was 200 ml
or 800 ml for [
3H]NMS saturation experiments. Approximately 30
and 10 mg of membrane proteins per sample were used for
[
3H]NMS and [
35S]GTPcS binding, respectively. N-methylsco-
polamine binding was measured directly in saturation experiments
using six concentrations (30 pM to 1000 pM) of [
3H]NMS for 1
hour. Depletion of radioligand was smaller than 20% for the
lowest concentration. For calculations, radioligand concentrations
were corrected for depletion. Agonist binding was determined in
competition experiments with 1 nM [
3H]NMS. Membranes were
first preincubated 60 min with agonists and IgG antibodies against
C-terminus of a-subunits of G-proteins, if applicable, and then
incubated with [
3H]NMS for additional 180 min. Final dilution of
antibodies was 1:200 for Gi/o and Gs/olf and 1:500 for Gq/11.
Nonspecific binding was determined in the presence of 10 mM
NMS. Agonist stimulated [
35S]GTPcS binding was measured in a
final volume of 200 ml of incubation medium with 200 pM (M1 or
M3 receptors) or 500 pM (M2 or M4 receptors) of [
35S]GTPcS and
5 mM( M 1 or M3 receptors) or 50 mM( M 2 or M4 receptors) GDP
for 20 min at 30uC after 60 min preincubation with GDP and
agonist. Nonspecific binding was determined in the presence of
1 mM unlabeled GTPcS. Incubations were terminated by filtration
through Whatman GF/F glass fiber filters (Whatman) using a
Tomtech Mach III cell harvester (Perkin Elmer, USA). Filters were
dried in vacuum for 1 h while heated at 60uC and then solid
scintillator Meltilex A was melted on filters (105uC, 90 s) using a
hot plate. The filters were cooled and counted in Wallac
Microbeta scintillation counter.
Scintillation proximity assay
In case of scintillation proximity assay, incubation with
[
35S]GTPcS as described above was terminated by membrane
solubilization by the addition of 20 ml of 10% Nonidet P-40. After
20 min 10 ml of individual primary antibodies against C-termini of
G-protein a-subunits were added and incubation was continued
for 1 h. The final dilution was 1:500 in case of anti-Gi/o-a and
anti-Gs/olf-a antibodies and 1:1000 in case of the anti-Gq/11-a
antibody. One batch of anti-rabbit IgG-coated scintillation beads
was diluted in 20 ml of incubation medium and 50 ml of the
suspension was added to each well for 3 h. Then plates were spun
for 15 min at 1,000 x g and counted using the scintillation
proximity assay protocol in a Wallac Microbeta scintillation
counter.
Data analysis
In general binding data were analyzed as described previously
[20]. Data were preprocessed by Open Office version 3.2 (www.
openoffice.org) and subsequently analyzed by Grace version 5.1
(plazma-gate.weizman.ac.il) and statistic package R version 2.13
(www.r-project.org) on Scientific Linux version 6 distribution of
GNU/Linux.
The following equations were fitted to data:
Saturation of radioligand binding
y~BMAX   x=(xzKD) ð1Þ
y, binding of radioligand at free concentration of radioligand x;
BMAX, maximum binding capacity; KD, equilibrium dissociation
constant.
Concentration-response
y~1z(EMAX-1)=(1z(EC50=x)
nH) ð2Þ
Pre-Coupling of Muscarinic Receptors
PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e27732y, radioactivity in the presence of agonist at concentration x
normalized to radioactivity in the absence of agonist; EMAX,
maximal increase by agonist; EC50, concentration of agonist
producing 50% of maximal effect; nH, Hill coefficient.
Interference of agonist with [
3H]NMS
y~(100-flow)   (1-x=(IC50highzx))zflow (1-x=(IC50lowzx)) ð3Þ
y, binding of radioligand at a concentration of displacer x
normalized to binding in the absence of displacer; flow, percentage
of low affinity sites; IC50high, concentration causing 50% decrease
in binding to high affinity sites; IC50low, concentration causing
50% decrease in binding to low affinity sites. Equilibrium
dissociation constant of displacer (KI) was calculated according
to Cheng and Prusoff [26].
Rate of association
y~Beq   (1-e-kobs x) ð4Þ
y, binding of radioligand at a time x; Beq, equilibrium binding;
kobs, observed rate of association.
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